TMS device approved for major depressive disorder in teens

Apollo TMS Therapy delivers targeted stimulation to specific brain regions responsible for mood and emotional regulation.

Key takeaways:

The Apollo TMS device was previously FDA cleared for treating MDD in adults.

TMS offers a non-pharmacologic alternative for this patient population.

The FDA has granted 510(k) clearance to an Atlanta-based medical technology firm for a transcranial magnetic stimulation device to treat major depressive disorder in adolescents.

Apollo TMS Therapy delivers targeted stimulation to specific brain regions responsible for mood and emotional regulation.

In a press release, neurocare group AG stated its Apollo TMS Therapy device was previously cleared by the FDA to treat MDD in adults who have not had success with previously prescribed oral antidepressants